With $37M Investment and New Corporate Partner, San Diego’s Cibus to Develop Enhanced Crop Strains for Europe
News Oct 12, 2009
Under the joint development partnership, Cibus will use its proprietary technology (which offers an alternative approach to inserting foreign genes to create genetically modified crops) to develop new plant traits in five unidentified crops for the European market. As part of the related agreement, Makhteshim-Agan, or MAI, will make its investments based on Cibus’s progress—and gradually acquire a 50.1 percent stake.
Cibus describes its technology, known as Rapid Trait Development System, or RTDS, as a “smart-breeding technology” that introduces desirable genetic traits in a plant by using directed mutagenesis, a process that takes advantage of mechanisms of gene repair. The company says that every time a cell copies its DNA, it makes “scrivener” errors, akin to typographical errors in the genetic code. Such variations are common, and according to Cibus, are part of natural variation. Cibus says its technology uses the DNA repair machinery that corrects such typos, and directs it instead to make changes in a specific way that produces the desired trait in the targeted gene.
Cibus hopes its approach will be acceptable to environmental groups and activists opposed to genetically modified organisms, or GMOs. The European market, in particular, has resisted introduction of genetically modified crops.
What’s in Your Wheat? Sequencing One of the Most Complex Genomes Known to ScienceNews
The wheat genome sequences may help biologists not only better understand the evolutionary history of wheat, but also advance the quest for hardier, more pest- and drought-resistant wheat types to help feed the world’s growing population.READ MORE
Scottish Equity Partners Announces Investment in DotmaticsNews
Scottish Equity Partners (SEP) completes a significant investment in Dotmatics.READ MORE
Horizon Discovery Partners with The Michael J. Fox FoundationNews
Innovative and relevant models for understanding alpha-synuclein biology and Parkinson’s disease pathogenesis in vivo.READ MORE
Comments | 0 ADD COMMENT
3rd Annual NGS Data Analysis and Informatics Conference
Feb 08 - Feb 09, 2018
3rd Annual Genome Editing & Engineering Conference
Feb 08 - Feb 09, 2018